Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Zeba N. Singh
Treatment of CD19-Positive Mixed Phenotype Acute Leukemias With Blinatumomab
American Journal of Hematology
Hematology
Related publications
Efficiency of Blinatumomab in a T(8;21) Acute Myeloid Leukemia Expressing CD19
Haematologica
Hematology
Blinatumomab: A New Treatment for Adults With Relapsed Acute Lymphocytic Leukemia
Clinical Journal of Oncology Nursing
Oncology
Blinatumomab, a Bi-Specific Anti-Cd19/Cd3 BiTE® Antibody for the Treatment of Acute Lymphoblastic Leukemia: Perspectives and Current Pediatric Applications
Frontiers in Oncology
Cancer Research
Oncology
Outcome of Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia After Blinatumomab Failure: No Change in the Level of CD19 Expression
American Journal of Hematology
Hematology
Effects of Bosutinib Treatment on Renal Function in Patients With Philadelphia Chromosome-Positive Leukemias
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Blinatumomab in Acute Lymphoblastic Leukemia
Expert Review of Anticancer Therapy
Oncology
Pharmacology
BRAF Mutations in Acute Leukemias
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Indirect Treatment Comparison of Inotuzumab Ozogamicin Versus Blinatumomab for Relapsed or Refractory Acute Lymphoblastic Leukemia
Advances in Therapy
Medicine
Pharmacology
Multiparameter Flow Cytometry Applications in the Diagnosis of Mixed Phenotype Acute Leukemia (MPAL)
Cytometry Part B - Clinical Cytometry
Forensic Medicine
Pathology
Histology
Cell Biology